Minerva Neurosciences, Inc. (NERV) Total liabilities 2017–2024
Minerva Neurosciences, Inc. (NERV) total liabilities at each fiscal year-end, per SEC filings.
$62.8MFY2024 · since FY2017: $52.1M → $62.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $62.8M | -26.4% |
| FY2023 | $85.4M | +13.6% |
| FY2022 | $75.1M | +8.6% |
| FY2021 | $69.1M | +1293.1% |
| FY2020 | $5.0M | -90.0% |
| FY2019 | $49.7M | +1.7% |
| FY2018 | $48.9M | -6.2% |
| FY2017 | $52.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More NERV financial trends
NERV RevenueNERV Net incomeNERV Net marginNERV Gross profitNERV Gross marginNERV Operating incomeNERV Operating marginNERV Operating cash flowNERV Free cash flowNERV Capital expendituresNERV Return on equityNERV Stock buybacksNERV Dividends paidNERV Total assetsNERV Shareholders’ equityNERV overview →